| __timestamp | Opthea Limited | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 10811000 |
| Thursday, January 1, 2015 | 2361587 | 33001000 |
| Friday, January 1, 2016 | 4472869 | 64936000 |
| Sunday, January 1, 2017 | 5030957 | 99909000 |
| Monday, January 1, 2018 | 4988941 | 127724000 |
| Tuesday, January 1, 2019 | 5196412 | 161524000 |
| Wednesday, January 1, 2020 | 6652774 | 182933000 |
| Friday, January 1, 2021 | 18418247 | 219982000 |
| Saturday, January 1, 2022 | 24827066 | 278139000 |
| Sunday, January 1, 2023 | 41896408 | 309799000 |
| Monday, January 1, 2024 | 15488619 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Opthea Limited and Ultragenyx Pharmaceutical Inc. offer a fascinating study in contrasts. From 2014 to 2023, Opthea's SG&A expenses grew by over 1,400%, peaking in 2023. Meanwhile, Ultragenyx's expenses surged by nearly 2,800% over the same period, reflecting its aggressive expansion strategy.
Opthea's expenses remained relatively stable until 2020, when they began to climb, reaching a high in 2023. In contrast, Ultragenyx consistently increased its SG&A spending, with a notable jump in 2015 and a peak in 2023. This divergence highlights differing strategic priorities: Opthea's cautious scaling versus Ultragenyx's rapid growth.
While 2024 data for Ultragenyx is unavailable, the trend suggests continued investment in SG&A, underscoring its commitment to growth.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
BeiGene, Ltd. or Opthea Limited: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and Dynavax Technologies Corporation
Ultragenyx Pharmaceutical Inc. and Novavax, Inc.: SG&A Spending Patterns Compared